Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on 5 TET. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106748662B reveals a high-yield synthetic route for Oxyresveratrol, offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN109053780A reveals a low-cost Raney Nickel oxidation route for Acalabrutinib intermediates, offering high purity and scalable supply chain solutions for global pharmaceutical manufacturers.
Patent CN108484586A details a novel epoxidation route for fragrance intermediates. This process offers significant supply chain stability and cost optimization for global buyers.
Patent CN110305010B details a high-yield Grignard carboxylation route for 2,5-dimethylphenylacetic acid, eliminating toxic cyanides and noble metal catalysts for cost-effective manufacturing.
Patent CN113292495B details a high-yield synthesis of (S)-amino benazepril intermediate using quinine-derived catalysis, offering significant cost and safety advantages for API manufacturing.
Patent CN103665064B details a novel three-step synthesis for high-purity sugar intermediates, offering significant cost reduction and scalable manufacturing solutions.
Novel patent CN114380736B details efficient synthesis of 2,3,4,5-tetrahydropyridine compounds using pincer ruthenium catalysts, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN103214487A reveals stable synthesis route. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Novel synthesis route for high-purity pharmaceutical intermediates. Reduces steps and improves yield for commercial scale-up.
Novel catalyst-free route for 1-phenyl-5-mercaptotetrazole offering high yield and safety advantages for statin drug manufacturing supply chains.
Patent CN117362314B enables one-step synthesis via Rh(III) catalysis. Delivers high-purity pharmaceutical intermediates with reduced safety risks and scalable manufacturing efficiency.
Patent CN114213365A discloses a high-yield synthetic route for empagliflozin intermediates using mild conditions, offering significant cost reduction in API manufacturing.
Advanced synthesis route for Lorcaserin intermediate offering cost reduction and scalability for pharmaceutical manufacturing supply chains globally.
Patent CN101370759B details a high-yield reduction of halogenated terephthalic acids. This process offers significant cost reduction in pharmaceutical intermediates manufacturing through optimized acid workup.
Patent CN107805225B reveals a green synthesis route for 5-mercapto tetrazole acetic acid, eliminating toxic methyl iodide and enabling cost-effective industrial scale-up for ceforanide production.
Advanced synthesis of 5-mercapto tetrazole acetic acid via patent CN107805225B. Offers superior yield, safety, and cost reduction for ceforanide intermediate supply chains.
Patent CN102241663B reveals a green aqueous synthesis for Strontium Ranelate. Achieve 90-95% yield with <0.3% impurities. Ideal for cost reduction in API manufacturing.
Patent CN117500789A reveals a novel synthesis route for pyridine borate ester intermediates, offering reduced diboron consumption and higher purity for scalable pharmaceutical manufacturing.
Patent CN101348445A reveals a pyridine-free route for phenylazo calix[4]arenes, offering safer manufacturing and tunable selectivity for reliable specialty chemical suppliers.
Advanced synthesis of 5-oxo-tetrahydropyran-3-carboxylic ester via Pd-catalyzed carbonylation. Offers cost reduction in API manufacturing and scalable production.